Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma

Fig. 2

The effect and prognosis of immunotherapy in group A were significantly better than those in group B. The OS (A) and RFS (B) of CM patients in group A were significantly better than those in group B. The effect of immunotherapy (C) and chemotherapy (D) in group A was significantly better than that in group B in CM. E. Comparison of the proportion of patients responding to immunotherapy between the two groups. Comparison of TIDE (F), Dysfunction (G), and Exclusion (H) scores between the two groups. I. Comparison of the expression of 8 common immune checkpoints between the two groups. *: P < 0.05; **: P < 0.01; ***: P < 0.001; ****: P < 0.0001

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us